Skip Ribbon Commands
Skip to main content
  
  
  
  
2018-CAVD-Grantee-Profiles.pdf
  
11/27/2018 4:11 PMBrian Sanders
AckermanAlter OPP1032817 Leveraging Antibody Effector Function.pdf
  
11/16/2018 9:41 AMBrian Sanders
Alt OPP1175860 Relevant and Rapidly Generated HIV-1 Vaccine Mouse Models.pdf
  
11/16/2018 9:41 AMBrian Sanders
Alter OPP1097381 A Genetic Approach to Optimizing the Antigenicity of HIV-1 Envelope.pdf
  
11/16/2018 9:41 AMBrian Sanders
Alter OPP1114729 Signatures of Antibody Responses that Correlate with Protection to Develop Down-Selection Criteria to Guide Vaccine Candidate Selection.pdf
  
11/19/2018 3:55 PMBrian Sanders
Baker OPP1111932 Nearest Neighbor Proposal.pdf
  
11/19/2018 3:43 PMBrian Sanders
Barouch OPP1107669 Therapeutic Efficacy of Potent Broadly Neutralizing mAbs for HIV-1 Eradication.pdf
  
11/16/2018 9:41 AMBrian Sanders
Barouch OPP1169339 Epitope Modified Env Trimers.pdf
  
11/16/2018 9:41 AMBrian Sanders
Batista OPP1185467 Accelerating Vaccine Design through Interrogation of Physiologically Relevant Mouse Models.pdf
  
12/4/2018 2:03 PMBrian Sanders
Busch OPP1115400 Assays for HIV Persistence.pdf
  
11/19/2018 3:43 PMBrian Sanders
Corey OPP1148133 Support for HVTN 702.pdf
  
11/16/2018 9:41 AMBrian Sanders
Crotty OPP1203211 Improving the identification of epitope-specific precursor naive B cells in the human B cell repertoire.pdf
  
11/27/2018 2:03 PMBrian Sanders
Farzan OPP1132169 eCD4ig.pdf
  
11/19/2018 3:43 PMBrian Sanders
Feinberg OPP1084519 IAVI Neutralizing Antibody Consortium.pdf
  
11/16/2018 9:41 AMBrian Sanders
Gallo OPP1017606 FLSC Phase I II Clinical Trials.pdf
  
11/16/2018 9:41 AMBrian Sanders
Gottardo OPP1151646 Vaccine Immunology Statistical Center.pdf
  
11/19/2018 3:43 PMBrian Sanders
Hassell OPP1147661 Vaccine Product Development Center - GMP Manufacturing, Toxicology, and Clinical Data Management.pdf
  
11/16/2018 9:41 AMBrian Sanders
Hassell OPP1153692 Vaccine Product Development Center.pdf
  
11/16/2018 9:41 AMBrian Sanders
Haynes OPP1094352 MPER-Peptide Liposome Immunogen Testing.pdf
  
11/16/2018 9:41 AMBrian Sanders
Haynes OPP1154951 Protein Production Facility.pdf
  
11/16/2018 9:41 AMBrian Sanders
Haynes OPP52282 Centralized Envelope Phase I Study.pdf
  
11/16/2018 9:41 AMBrian Sanders
Ho OPP1040731 Engineered Bispecific bNabs for Prevention.pdf
  
11/16/2018 9:41 AMBrian Sanders
Ho OPP1169162 First in human clinical evaluation of 10E8.4-iMab, a potent and broad bispecific antibody against HIV.pdf
  
11/16/2018 9:41 AMBrian Sanders
Johnson OPP1110661 Singel Cell Transcriptomics.pdf
  
11/19/2018 3:43 PMBrian Sanders
Jolicoeur OPP1146356 A new class of immunogens for raising broadly neutralizing antibodies.pdf
  
11/16/2018 9:42 AMBrian Sanders
Kamarck OPP1187970 Clinical Assessment of hCMV-HIV Prototype Vector.pdf
  
11/16/2018 9:42 AMBrian Sanders
Kay OPP1154293 NHP Evaluation of New AAV Vectors.pdf
  
11/19/2018 3:45 PMBrian Sanders
Koup OPP1032325 Comprehensive Cellular Vaccine Immune Monitoring Consortium.pdf
  
11/16/2018 9:42 AMBrian Sanders
Kublin 1088039 HIV Vaccine Trials Site Development for the P5 Program.pdf
  
11/19/2018 3:43 PMBrian Sanders
Kublin OPP1110792 HVTN_100.pdf
  
11/19/2018 3:43 PMBrian Sanders
Kublin OPP1165951 HVTN 705 Phase 2b efficacy trial of Ad26 and gp140.pdf
  
11/19/2018 3:43 PMBrian Sanders
Lewis OPP1033109 Ab Specificity and Fc-Mediated Protection.pdf
  
11/16/2018 9:42 AMBrian Sanders
Masopust OPP1116224 Vaccination for prevention of HIV.pdf
  
11/16/2018 9:42 AMBrian Sanders
McElrath OPP1107954 Durability of Ab Response.pdf
  
11/19/2018 3:43 PMBrian Sanders
McMichael OPP11133649 HLA-E Restriction.pdf
  
11/16/2018 9:42 AMBrian Sanders
Montefiori OPP1146996 Antibody Vaccine Immune Monitoring Consortium.pdf
  
11/16/2018 9:42 AMBrian Sanders
Moore OPP1132237 BG505 SOSIP664 Trimer HIV Vaccines.pdf
  
11/16/2018 9:42 AMBrian Sanders
Nussenzweig OPP1033115 Isolation of Human Monoclonal Abs for HIV Prevention.pdf
  
11/19/2018 3:43 PMBrian Sanders
Nussenzweig OPP1092074 Clinical Trial of Broadly Neutralizing anti-HIV Antibodies.pdf
  
11/27/2018 4:11 PMBrian Sanders
Nussenzweig OPP1124068 bnAb Development.pdf
  
11/16/2018 9:42 AMBrian Sanders
Nussenzweig OPP1168933 Phase 1 studies of the pharmacokinetics, safety, and bioactivity of 3BNC117-LS and 10-1074-LS among adults in the US and sub-Saharan Africa.pdf
  
11/19/2018 3:43 PMBrian Sanders
Pantaleo OPP1040705 RepliVax Vaccine Platform.pdf
  
11/16/2018 9:42 AMBrian Sanders
Pantaleo OPP1114725 Generation-Isolation of Novel bnAbs from Lymph Node B cells.pdf
  
12/4/2018 9:07 AMBrian Sanders
Pantaleo OPP1190237 Optimization of the LN02 Anti-HIV Broadly Neutralizing Antibody.pdf
  
12/4/2018 9:07 AMBrian Sanders
Pantaleo OPP38599 OPP52845 Poxvirus-Based Vaccine Development.pdf
  
11/19/2018 3:43 PMBrian Sanders
Parks OPP1148476 HIV Vaccine Clinical Candidates.pdf
  
11/19/2018 3:43 PMBrian Sanders
Parks OPP1152832 HIV Vaccine Clinical Candidates.pdf
  
11/16/2018 9:42 AMBrian Sanders
Pettit OPP1138851 Just Biotherapeutics.pdf
  
11/16/2018 9:42 AMBrian Sanders
Picker OPP1107409 Development of CVM Vector Based Vaccine.pdf
  
11/16/2018 9:42 AMBrian Sanders
Picker OPP1108533 MHC II, E CD8+ T Cells HIV Control of HIV.pdf
  
11/16/2018 9:42 AMBrian Sanders
Pulendran OPP1040768 Protective humoral responses against HIV.pdf
  
11/16/2018 9:42 AMBrian Sanders
Reinherz OPP1108179 HIV clade C MPER Immunogens.pdf
  
11/19/2018 3:43 PMBrian Sanders
Shattock OPP1084580 DNA Vaccination for HIV Immunogen Discovery.pdf
  
11/16/2018 9:42 AMBrian Sanders
Shaw OPP1145046 Novel SHIV Design to Elicit Broadly Neutralizing Antibodies and Guide Iterative Vaccine Development.pdf
  
11/19/2018 3:43 PMBrian Sanders
Überla OPP1040727 Antibodies without HIV T helper cells.pdf
  
11/19/2018 3:43 PMBrian Sanders
Walker OPP1066973 bnAbs after Infection and Immunization.pdf
  
11/16/2018 9:42 AMBrian Sanders
Walker OPP1146433 Implications for vaccine design from T and B cell mechanisms of HIV control.pdf
  
11/16/2018 9:42 AMBrian Sanders
Ward OPP1115782 Analytics Network for Env Immunogen Characterization.pdf
  
11/19/2018 3:43 PMBrian Sanders
Watson OPP1147797 mRNA Encoded Abs for HIV Prophylaxis.pdf
  
11/16/2018 9:42 AMBrian Sanders